Aminodat Jun 2026

By providing the most comprehensive, up-to-date, and regionally relevant data on feed ingredients, AMINODat® empowers professionals to:

, it is widely considered the most extensive database of its kind in the world. Key Features of AMINODat®

The SID values in AMINODat® are consistently validated against animal trial data to ensure they reflect true digestibility in vivo. Applications in Livestock Production The data provided by AMINODat® is invaluable for:

For any professional serious about animal nutrition, AMINODat® is more than a database; it is the definitive reference that has set the industry standard for over two decades. Its evolution from a simple book to a dynamic, web-based platform reflects the increasing complexity and demands of modern agriculture. aminodat

: Includes data from over 1.2 million feed ingredient samples globally.

AminoData works by providing your body with a concentrated dose of EAAs, which are then absorbed into the bloodstream and transported to your muscles. This leads to a number of benefits, including:

A: Technically, yes, because it contains peptides. However, due to zero carbohydrates and negligible calories (under 15 kcals), it does not spike insulin and is considered "fasting-compatible" for autophagy-focused fasts. Its evolution from a simple book to a

: It began as a printed compilation of global amino acid profiles, helping formulators move away from broad nutritional guesswork.

, on amino acid availability, which can otherwise lead to reduced animal performance. Efficiency

Removes the influence of basal endogenous losses (amino acids secreted by the animal itself), providing a constant value for the ingredient regardless of the diet formulation. This leads to a number of benefits, including:

AMINODat is more than a simple spreadsheet; it is an interactive ecosystem that integrates with other Evonik services like AMINONIR (Near-Infrared Spectroscopy for rapid analysis).

A: Current scientific literature does not show large-scale, randomized controlled Phase III trials specifically for the "Aminodat" variant. Most academic references to amino-analogues involve animal nutrition databases or basic structural chemistry rather than human therapeutic endpoints.